Navigation Links
Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds
Date:7/15/2010

lex ways than one might have imagined. The panel did the best they could with data that weren't completely conclusive, that suggested an increased risk but didn't make it clear how much that increased risk was," he said.

And he explained, "The majority of the panel didn't feel the increased risk was enough to summarily remove a drug that hundreds of thousands of people are taking successfully."

A second heart expert agreed.

"I didn't think that the evidence was yet compelling enough to withdraw the product from the market," said Dr. Kirk Garratt, clinical director of interventional cardiovascular research at Lenox Hill Hospital in New York City. "It sounds like they're going to add some new warnings regarding the risk, and that seems like an appropriate step."

And such a step will likely decrease the use of Avandia, anyway, Garratt added. "Use went down pretty sharply after criticism started to fly and the presence of new boxed warnings will further depress the prevalence of this product in the marketplace," he said.

But Garratt also said he didn't think the experts' votes would end the controversy over Avandia.

"There is so much dissent within the FDA about the appropriate action to take with this drug that I can't imagine this will be the final world," he said. "Also, we've got an alternative product [Actos] that seems to be essentially as effective at controlling diabetes but hasn't been linked to the cardiovascular risks."

In a statement released after the vote, Dr. Ellen Strahlman, chief medical officer at GlaxoSmithKline, which makes Avandia, said, "Following today's recommendations, we will, of course, continue to work with the FDA in the best interest of diabetes patients ... Patients taking Avandia should speak with their physician about their treatment and any questions they may have regarding the safety of the medicine."

The FDA committee had been meeting intensively since early Tuesday morning, hearing di
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. FDA Panel Seems Skeptical Over Key Avandia Data
2. FDA Panel Appears Skeptical Over Key Avandia Data
3. Avandia Heart Risks Buried by Drug Company: Report
4. FDA Reviewer Questions Results of Key Avandia Trial
5. Latest Study on Diabetes Drug Avandia Finds No Heart Risks
6. Diabetes Drug Avandia Ups Heart Risk, Reviews Conclude
7. Maher Law Firm Warns Avandia Users - NY Times Reports - FDA Recommends Recall of Avandia
8. FDA: No Decision on Whether to Pull Diabetes Drug Avandia Off the Market
9. FDA Says It Hasnt Decided Whether to Pull Diabetes Drug Avandia Off the Market
10. Remove Diabetes Drug Avandia From Market: FDA Documents
11. Remove Diabetes Drug Avandia From Market: FDA Reports
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds
(Date:11/28/2014)... a leader in the wig industry, has announced a great ... promotion features: , > 400 pieces of FOUR ... (no coupon code needed), > 10% off for ... $49 , Visit http://www.uniwigs.com for more details , The ... 1st and the first 100 shoppers each day will receive our ...
(Date:11/28/2014)... Georgia (PRWEB) November 28, 2014 Patten ... and locally grown. With those passions driving them, they've ... Georgia Grown. Having tried other pecans oils, they've found ... Pitts, Georgia to be exceptionally flavorful, retaining the buttery ... The same nutritional benefits found in pecans ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 An inventor from ... day to day. "I got this idea while lying in ... the bathroom," he said. , The Bed Buddy provides a ... go to the bathroom. It eliminates the need to leave ... promotes comfort and dignity. Easy to use and producible in ...
(Date:11/28/2014)... Before that Thanksgiving meal even had time to ... shopping season. Today, people will stand in line for hours ... retail shopping day of the year. , But instead ... Albany dentist Dr. Ronald Receveur is asking the public ... literally brighten a few smiles. , The gifts he suggests ...
(Date:11/28/2014)... Colorado (PRWEB) November 28, 2014 talklocal ... connect consumers to the right service professionals by phone in ... week after at least two tornadoes were reported to have ... Although no damage was reported following the tornadoes, Denver residents ... for the unexpected. Having TalkLocal is like having local pros ...
Breaking Medicine News(10 mins):Health News:Pre-X'mas Crazy Sale Starts from $0 at UniWigs.com 2Health News:Patten Pecans Goes Local with Nutritious Georgia Pecan Oil 2Health News:New Albany Dentist Offers Gift Ideas That Can Improve Oral Health 2Health News:New Albany Dentist Offers Gift Ideas That Can Improve Oral Health 3Health News:New Albany Dentist Offers Gift Ideas That Can Improve Oral Health 4Health News:TalkLocal Launches In Denver A Week After Multiple Tornadoes Hit Near City 2
... Yet another Major Rise in Listeners. Affordable Health Insurance and ... ... Kansas City, MO (PRWEB) August 28, 2008 -- The Health Insurance ... September 6th on 1260 AM and 104.1 FM KSGF. The ...
... RDYN ) today announced the restructuring of ... 80% to 5 employees in,actions that are scheduled ... As a result of these actions Replidyne will ... for the,treatment of Clostridium difficile (C. difficile) bacteria ...
... Oncology has selected renowned pediatric oncologist Audrey Evans, M.D., ... recognized during the Awards Ceremony held Tuesday, September 23, ... Boston., Dr. Evans has been on the forefront of ... She was one of the co-founders of the original ...
... longer to see positive effect, researchers say , , WEDNESDAY, Aug. ... not lower the rate of stroke, cardiovascular events or diabetes ... stroke, a new study finds. , Telmisartan is an angiotensin ... chemicals that constrict the blood vessels enabling the blood to ...
... wages and benefits, HEMET, Calif., Aug. 27 The ... against the,board of directors of Valley Health System (VHS) for ... already voted to agree to., "I do this job ... said,Lisa Howell, a registered nurse at Menifee Valley Medical Center. ...
... use 7 simple variables to gauge in-hospital mortality ... News) -- A new scoring system for assessing ... been confirmed to be effective, according to Mayo ... The Mayo Clinic Risk Score (MCRS) uses seven ...
Cached Medicine News:Health News:The Health Insurance Advocate Radio Show Expands to Springfield, Missouri, and Reaches a New All-Time Ratings High for Female Listenership 2Health News:The Health Insurance Advocate Radio Show Expands to Springfield, Missouri, and Reaches a New All-Time Ratings High for Female Listenership 3Health News:Replidyne Announces Restructuring of Operations 2Health News:ASTRO selects pediatric oncologist as 2008 honorary member 2Health News:Newer Blood Pressure Drug No Better Than Placebo in Preventing Stroke 2Health News:Newer Blood Pressure Drug No Better Than Placebo in Preventing Stroke 3Health News:State Board Issues Complaint: VHS Board Should Have Signed Contract With Caregivers 2Health News:Angioplasty Scoring System Predicts Risk of Death 2
(Date:11/26/2014)... -- Cohen, Placitella & Roth, PC is investigating potential ... Pharmaceutical Corporation ("Nymox" or "Company") (NASDAQ: ... 2011 through November 2, 2014 ("Class Period").  The ... officers and directors publically disseminated materially false and/or ... 20(a) of the Securities Exchange Act of 1934 ...
(Date:11/26/2014)... Md. , Nov. 26, 2014  Over 100 ... of those suffer from this pain daily. Chronic and ... of pain management is born to fulfill the need ... all types of pain. On October 28th, ... the Cumberland, Maryland community.  This ...
(Date:11/26/2014)... -- Zynerba Pharmaceuticals , Inc., a specialty pharmaceutical ... cannabinoid treatments, today announced that the company will present ... The conference will be held December 2 to 3, ... York . Zynerba,s Chairman and CEO, Armando ... December 2. To listen to a webcast ...
Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3New Pain Management Center Opens in Cumberland, Md. 2Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2
... Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY ) announced ... a Phase 2 clinical trial using intravenous administration ... in patients with non-small cell lung cancer (NSCLC) ... is Dr. Miguel Villalona-Calero, Professor, Division of Hematology/Oncology ...
... quantitative imaging endpoints from MRI analysesROCHESTER, N.Y., March ... ), a leading provider of quantitative imaging for ... Canadian medical device company based in Laval, Quebec, ... pivotal clinical trial for its cartilage repair device ...
Cached Medicine Technology:Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours 2VirtualScopics' Quantitative Imaging Provides Primary Endpoint in Cartilage Repair Pivotal Clinical Trial 2VirtualScopics' Quantitative Imaging Provides Primary Endpoint in Cartilage Repair Pivotal Clinical Trial 3
20 g MVR knife. Dimensions: 31.8 mm x 1.18 mm x 2.7 mm....
Full Handle Laseredge Spoon Blade Knife, 3.0 mm angled double bevel. Blade dimension: 11.0 mm (L) x 3.0 mm (W). Cut: 320....
Full Handle Laseredge Slit Blade Knife, 3.2 mm angled double bevel. Blade tip dimension: 14.4 mm x 3.2 mm x 4.0 mm....
Full Handle Laseredge Slit Blade Knife, 3.0 mm angled bevel up. Blade tip dimension: 14.4 mm x 3.0 mm x 3.7 mm....
Medicine Products: